These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 28229846

  • 1. [Diagnostic and Therapeutic Approach of Chronic Spontaneous Urticaria: Recommendations in Portugal].
    Costa C, Gonçalo M, GPEU – Grupo Português de Estudos de Urticária.
    Acta Med Port; 2016 Nov; 29(11):763-781. PubMed ID: 28229846
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticaria.
    Ferrer M, Boccon-Gibod I, Gonçalo M, İnalöz HS, Knulst A, Lapeere H, Parthasaradhi A, Stingl G, Tagka A, Valenzuela F, Yeung J, Thomsen SF.
    Eur J Dermatol; 2017 Oct 01; 27(5):455-463. PubMed ID: 29084635
    [Abstract] [Full Text] [Related]

  • 7. Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population.
    Kulthanan K, Tuchinda P, Chularojanamontri L, Likitwattananurak C, Ungaksornpairote C.
    J Dermatolog Treat; 2017 Mar 01; 28(2):160-165. PubMed ID: 27388043
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practice.
    Vollono L, Piccolo A, Lanna C, Esposito M, Bavetta M, Campione E, Bianchi L, Diluvio L.
    Drug Des Devel Ther; 2019 Mar 01; 13():3181-3186. PubMed ID: 31564834
    [Abstract] [Full Text] [Related]

  • 10. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
    Staubach P, Metz M, Chapman-Rothe N, Sieder C, Bräutigam M, Canvin J, Maurer M.
    Allergy; 2016 Aug 01; 71(8):1135-44. PubMed ID: 27010957
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Omalizumab for the treatment of chronic urticaria.
    Zuberbier T, Maurer M.
    Expert Rev Clin Immunol; 2015 Feb 01; 11(2):171-80. PubMed ID: 25566680
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
    Kitsioulis NA, Xepapadaki P, Roussaki-Schulze AV, Papadopoulos N, Zafiriou E.
    Int Arch Allergy Immunol; 2017 Feb 01; 172(3):161-166. PubMed ID: 28380487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.